MCKESSON CORP (MCK) is a large-cap growth stock in the Major Drugs industry. The rating using this strategy is 93% based on the firm’s underlying fundamentals and the stock’s valuation.

MCKESSON CORP (MCK) is a large-cap growth stock in the Major Drugs industry. The rating using this strategy is 88% based on the firm’s underlying fundamentals and the stock’s valuation.

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Buying $1000 In MCK: If an investor had bought $1000 of MCK stock 5 years ago, it would be worth $5,223.62 today based on a price of $647.88 for MCK at the time of writing.

On March 6, 2025, McKesson Corporation (NYSE:MCK) stock closed at $641.69 per share with a market capitalization of $80.42 billion. Conventum – Alluvium Global Fund stated the following ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $695.00. The ...

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” fourth-quarter 2024 ...

McKesson (MCK) closed the latest trading day at $640.66, indicating a -1.92% change from the previous session's end. This move lagged the S&P 500's daily gain of 0.49%. On the other hand, the Dow ...

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.